Impact of first-line arsenic trioxide and retinoic acid treatment on outcome in therapy-related acute promyelocytic leukemia patients Meeting Abstract


Authors: Kayser, S.; Krzykalla, J.; Norsworthy, K.; Elliott, M.; Grimwade, D.; Hills, R. K.; Gonzales, P.; Racil, Z.; Mayer, J.; Baer, M. R.; Novak, J.; Zak, P.; Szotkowski, T.; Russell, N. H.; Westermann, J.; Walter, R. B.; Estey, E. H.; Gorner, M.; Benner, A.; Kramer, A.; Smith, B. D.; Burnett, A. K.; Thiede, C.; Rollig, C.; Ho, A. D.; Ehninger, G.; Tallman, M.; Levis, M. J.; Platzbecker, U.
Abstract Title: Impact of first-line arsenic trioxide and retinoic acid treatment on outcome in therapy-related acute promyelocytic leukemia patients
Meeting Title: Acute Leukemias XVI: Biology and Treatment Strategies
Journal Title: Annals of Hematology
Volume: 96
Issue: Suppl. 1
Meeting Dates: 2017 Feb 19-22
Meeting Location: Munich, Germany
ISSN: 0939-5555
Publisher: Springer  
Date Published: 2017-02-01
Start Page: S75
End Page: S76
Language: English
ACCESSION: WOS:000394105400113
PROVIDER: wos
PUBMED: 28105492
DOI: 10.1007/s00277-017-2921-1
Notes: Meeting Abstract: 70 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    651 Tallman